Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Adaptive Phage Therapeutics Enters Collaboration and License Agreement with Hebrew University of Jerusalem and Hadassah Medical Center
Thursday, May 25, 2023Adaptive Phage Therapeutics APT a clinicalstage biotechnology company pioneering the development of phagebased therapies to combat bacterial infections is pleased to announce a collaboration and license agreement with the Israeli Phage Therapy Center...
Nona Biosciences Enters into Antibody Discovery Agreement with OPKO Health's ModeX Therapeutics
Wednesday, May 24, 2023Nona Biosciences a whollyowned subsidiary of HBM Holdings Limited committed to cuttingedge antibody technology innovation and provider of integrated solutions from Idea to IND I to ITM today announced it has entered into an agreement with ModeX Thera...
Food and Drug Administration (FDA) and Clarivate Extend Material Transfer Agreement for Three Additional Years
Wednesday, May 24, 2023Clarivate Plc NYSE CLVT a global leader in connecting people and organizations to intelligence they can trust to transform their world today announced the extension of the Material Transfer Agreement MTA with the FDA for an additional three years The...
Akebia Announces UK MHRA Approval of Vafseo® (vadadustat) for the Treatment of Symptomatic Anemia Associated with Chronic Kidney Disease in Adults on Chronic Maintenance Dialysis
Tuesday, May 23, 2023Akebia Therapeutics Inc Nasdaq AKBA today announced that the United Kingdom UK Medicines and Healthcare products Regulatory Agency MHRA has granted marketing authorization for Vafseo vadadustat an oral hypoxiainducible factor prolyl hydroxylase HIFPH...
PolyPid Announces FDA Agreement on the Design of SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for Prevention of Abdominal Colorectal Surgical Site Infections
Tuesday, May 23, 2023PolyPid Ltd Nasdaq PYPD PolyPid or the Company a latestage biopharma company aiming to improve surgical outcomes today announced that the US Food and Drug Administration FDA agreed to Companys SHIELD II Phase trial design evaluating DPLEX for the pr...
Medigene AG Expands Patent Portfolio for its End-to-End Platform
Tuesday, May 23, 2023Medigene AG Medigene FSE MDG Prime Standard an immunooncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors announced today that the Company has been issued a patent by the Japan Patent Office p...
Sangamo Therapeutics Receives U.S. FDA Fast Track Designation for Isaralgagene Civaparvovec for the Treatment of Fabry Disease
Tuesday, May 23, 2023Sangamo Therapeutics Inc Nasdaq SGMO a genomic medicine company today announced that the US Food and Drug Administration FDA has granted Fast Track Designation to isaralgagene civaparvovec or ST a wholly owned gene therapy product candidate for the t...
Thousand Oaks Biologics and GeneQuantum Healthcare Signed A Strategic Partnership Agreement for ADC Drug Development
Monday, May 22, 2023Thousand Oaks Biologics Inc TOBio and GeneQuantum Healthcare Suzhou Co Ltd GQ are pleased to announce that they have formed a strategic partnership focusing on the CMC development of ADC products with a core conjugation technology for more stable dru...
Avrobio Announces Agreement to Sell Cystinosis Gene Therapy Program for $87.5 Million
Monday, May 22, 2023AVROBIO Inc Nasdaq AVRO a leading clinicalstage gene therapy company working to free people from a lifetime of genetic disease today announced an agreement to sell its investigational hematopoietic stem cell HSC gene therapy program for the treatment...
Thermo Fisher Scientific Expands Steriles Manufacturing and Research Capabilities in Asia-Pacific Region
Saturday, May 20, 2023Thermo Fisher Scientific the world leader in serving science has opened a new sterile drug facility in Singapore that will better enable customers to deliver new medicines and vaccines in the AsiaPacific market The new facility also marks a significa...
